The DDHD2 Gene SPG54 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DDHD2 gene, which are associated with Spastic Paraplegia 54 (SPG54). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSP), characterized by progressive weakness and spasticity of the legs. Early and accurate diagnosis through this test enables better management and understanding of the condition, offering insights into potential treatment and therapy options. The test cost is set at 4400 AED, reflecting the comprehensive analysis and detailed report provided by DNA Labs UAE, a leading facility in genetic diagnostics.
The C12ORF65 gene, associated with spastic paraplegia 55 (SPG55), is a critical focus in genetic testing for individuals experiencing symptoms of this inherited condition. Spastic paraplegia 55 is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The C12ORF65 gene plays a significant role in mitochondrial function, and mutations in this gene can disrupt cellular energy production, leading to the symptoms observed in SPG55.
DNA Labs UAE offers a specialized genetic test targeting the C12ORF65 gene to diagnose SPG55. This test is essential for individuals presenting symptoms of spastic paraplegia, as it can confirm the diagnosis and help in the management of the condition. The test involves analyzing the patient's DNA to identify mutations in the C12ORF65 gene that are known to cause SPG55.
The cost of the C12ORF65 gene SPG55 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the comprehensive analysis of the C12ORF65 gene. Upon completion of the test, a detailed report is provided, outlining the findings and their implications for the patient's health and treatment options. This genetic test is a valuable tool for affected individuals and their families to understand their genetic makeup and to make informed decisions regarding their health care and management of the condition.
The CYP2U1 gene SPG56 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CYP2U1 gene, which have been associated with a rare neurological disorder known as spastic paraplegia 56 (SPG56). This condition is part of a group of genetic disorders known as hereditary spastic paraplegias (HSPs), which are characterized by progressive stiffness and contraction (spasticity) in the lower limbs. The CYP2U1 gene plays a crucial role in the nervous system's development and function, and mutations in this gene can lead to the symptoms observed in SPG56.
The test is conducted at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the CYP2U1 gene. This test is critical for individuals with a family history of HSPs or those exhibiting symptoms of SPG56, as it can provide a definitive diagnosis of the condition.
The cost of the CYP2U1 gene SPG56 genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, laboratory analysis, and a comprehensive report detailing the test results. It's important for patients considering this test to consult with a healthcare provider or genetic counselor to understand the implications of the results and to discuss potential treatment options and management strategies for SPG56.
The TFG Gene SPG57 Genetic Test is a specialized diagnostic tool used to identify mutations in the TFG gene, which are associated with SPG57, a form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and weakness of the legs, resulting from the degeneration of nerve pathways responsible for transmitting signals from the brain to the spinal cord and then to the muscles.
DNA Labs UAE offers this genetic test to help in the diagnosis and management of SPG57. By analyzing a sample of the patient's DNA, the test can detect specific genetic alterations in the TFG gene that are linked to the condition, providing crucial information for accurate diagnosis, treatment planning, and genetic counseling.
The cost of the TFG Gene SPG57 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the sophisticated laboratory procedures and expert analysis required to identify the presence of the genetic mutation associated with SPG57. For patients and families affected by hereditary spastic paraplegia, this test represents a critical step towards understanding their condition and making informed health care decisions.
The USP8 Gene SPG59 USP8 Related Genetic Test is a specialized diagnostic procedure designed to identify mutations in the USP8 gene, which are linked to Spastic Paraplegia 59 (SPG59). SPG59 is a rare genetic disorder characterized by progressive weakness and spasticity of the legs. This condition is part of a group of disorders known as hereditary spastic paraplegias, which affect the nerve pathways from the brain to the muscles.
The test specifically targets the USP8 gene to detect any genetic anomalies that may be responsible for the symptoms associated with SPG59. By analyzing the genetic material, healthcare providers can gain crucial insights into the condition, enabling them to make more informed decisions regarding the patient's management and treatment plans.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the USP8 Gene SPG59 USP8 Related Genetic Test is performed with the highest standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided.
For patients exhibiting symptoms of SPG59 or those with a family history of hereditary spastic paraplegias, this test offers a valuable diagnostic tool. Early detection through genetic testing can significantly impact the management of the condition, potentially improving the quality of life for those affected.
The CYP7B1 gene SPG5A genetic test is a specialized diagnostic tool designed to identify mutations in the CYP7B1 gene, which are linked to Spastic Paraplegia 5A (SPG5A). SPG5A is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive weakness and spasticity of the legs. Mutations in the CYP7B1 gene disrupt the normal function of enzymes involved in cholesterol metabolism, leading to the symptoms associated with SPG5A.
This genetic test involves analyzing the patient's DNA to detect specific mutations in the CYP7B1 gene that are known to cause SPG5A. It is a crucial step in the diagnosis of SPG5A, allowing for a precise genetic diagnosis that can inform treatment strategies, provide information on the course of the disease, and offer insight into the risk of passing the condition on to future generations.
The test is available at DNA Labs UAE, a leading facility for genetic testing in the United Arab Emirates. The cost of the CYP7B1 gene SPG5A genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis involved in identifying the genetic mutations associated with SPG5A, utilizing advanced genomic technologies to ensure accurate and reliable results. Patients considering this test should consult with a healthcare professional or genetic counselor to understand the implications of the test results and to receive personalized advice based on their specific situation.
The NIPA1 Gene SPG6 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NIPA1 gene, which are associated with Spastic Paraplegia 6 (SPG6), a rare genetic disorder. This condition is characterized by progressive weakness and stiffness of the legs, which can lead to difficulty walking and other mobility issues. The test aims to provide definitive genetic evidence for the condition, aiding in accurate diagnosis and management.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the NIPA1 gene that are known to cause SPG6. This precise genetic testing can be crucial for affected individuals and their families for understanding the condition, potential treatments, and genetic counseling.
The cost of the NIPA1 Gene SPG6 Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions and supports planning for the future.
The WDR48 gene, associated with SPG60 (Spastic Paraplegia 60), plays a crucial role in various cellular processes, including the regulation of autophagy and endosomal trafficking. Mutations in the WDR48 gene can lead to SPG60, a form of hereditary spastic paraplegia characterized by progressive weakness and spasticity of the lower limbs. The condition may also present additional neurological symptoms depending on the severity and specific mutation involved.
To diagnose and understand the genetic basis of SPG60 in affected individuals, DNA Labs UAE offers a specialized genetic test targeting the WDR48 gene. This test is designed to identify mutations within the WDR48 gene that could be responsible for the condition, providing essential information for accurate diagnosis, management, and genetic counseling.
The cost of the WDR48 gene-related genetic test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring high accuracy and reliability of the results. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of SPG60, facilitating informed decisions regarding treatment options and lifestyle adjustments to better manage the condition.
The ARL6IP1 gene, associated with SPG61, is a critical genetic marker for diagnosing hereditary spastic paraplegia type 61 (SPG61), a rare neurodegenerative disorder. This condition is characterized by progressive weakness and spasticity of the lower limbs due to the degeneration of the corticospinal tract neurons. The ARL6IP1 gene plays a significant role in the maintenance and function of the nervous system, and mutations in this gene can lead to the clinical manifestations of SPG61.
To accurately diagnose this condition, a genetic test targeting the ARL6IP1 gene can be conducted. In the UAE, this specialized test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test involves analyzing the patient's DNA to identify mutations in the ARL6IP1 gene that are indicative of SPG61. This genetic test is crucial for confirming the diagnosis, understanding the prognosis, and guiding the management and treatment plans for affected individuals.
The cost of the ARL6IP1 gene SPG61 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any genetic alterations in the ARL6IP1 gene, providing patients and their families with essential information for managing the condition. Given the complexity of hereditary spastic paraplegia and the importance of early intervention, this genetic test is a valuable tool in the diagnostic process, offering insights that can significantly impact the quality of life of those affected by SPG61.
The AMPD2 Gene SPG63 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AMPD2 gene, which are associated with Spastic Paraplegia 63 (SPG63). SPG63 is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive stiffness and weakness of the legs. The AMPD2 gene plays a critical role in the development and maintenance of the nervous system, and mutations in this gene can lead to various neurological symptoms, including difficulties with walking and coordination.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the AMPD2 gene that could lead to SPG63. It is a crucial tool for healthcare providers in diagnosing this rare condition, enabling them to offer appropriate management and treatment options for affected individuals. Early diagnosis can also help in understanding the progression of the disease and in providing genetic counseling to families.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the AMPD2 Gene SPG63 Genetic Test is 4400 AED. DNA Labs UAE employs advanced genetic testing technologies and methodologies to ensure accurate and reliable results, offering patients and their families critical insights into their genetic health.
